What we know about Eli Lilly's orforglipron If all goes well for Lilly, orforglipron could be up for FDA approval for weight management by the end of 2025, and for type 2 diabetes treatment in 2026
However, until it receives regulatory approval from the MHRA or EMA, it cannot be recommended for use outside of clinical trials
There are a number of DAO supplements available over the counter, but be careful ordering from Amazon may be convenient, but its also where fake and/or poor-quality supplements run galore
With similar capabilities now offered by D2C healthcare companies like Hims, Noom, Ro, and WeightWatchers, differentiation will hinge on cost and accessible coaching/supportespecially guidance through untested areas like microdosing weight loss drugs
To start, 28 healthy volunteers who had never taken a psychedelic were given 1mg of psilocybin, a small enough dose to be considered a placebo
& Safdar, N